Mary Costello

A new global Tufts CSDD survey of 387 investigative site professionals reveals broad experience with digital and decentralized trial tools, growing site-driven technology investments, and strong support for remote data collection—while highlighting persistent burdens tied to fragmented systems, training demands, and financial strain.

Has technology taken the industry too far?

Decentralized clinical trials (DCTs) have ignited clinical transformation while the COVID-19 pandemic has fueled their rapid expansion.

Pressure to shorten study start-up timelines puts clinical supply management in the crosshairs.

From tactical to strategic: tracking the evolution of global clinical supply chain management.